Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine
(αS)-α-methylbenzeneethanamine
(S)-(+)-β-phenylisopropylamine
Desamfetamina
Dexamfetaminum
Dextroamphetamine adipate
(+)-α-methylphenethylamine
Dexamfetamine
(+)-(S)-amphetamine
Dexamfetamina
Dextroamphetamine saccharate
(S)-1-phenyl-2-propylamine
(+)-α-methylphenylethylamine
(S)-α-methylbenzeneethanamine
(S)-amphetamine
Dextroamphetamine sulfate
(+)-amphetamine
(S)-(+)-amphetamine
(S)-1-phenyl-2-aminopropane
d-amphetamine
Dexanfetamina
Dexamphetamine
Brand Names
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
